Aortic stenosis is one of the most common and serious heart valve disease problems. However, many patients are unaware or undiagnosed, which is why the Ãå±±ÊÓÆµ continues to drive efforts for timely diagnosis, appropriate treatment, improved quality of care initiatives and comprehensive patient and caregiver resources to combat the disease.
To tackle the problem, we have launched Target: Aortic Stenosis. The goal of the Target: Aortic Stenosis program is to enhance the patient experience from symptom onset to appropriate diagnosis and follow-through, to timely treatment and disease management. The program consists of evidence-based measurement development to better identify and treat patients, as well as multi-media educational resources and self-management care plans for people living with structural heart disease.
What Sites are Saying
Teams participating in Target: Aortic Stenosis continue to share compelling reflections on their experience with the program. Many note how the framework helps streamline workflows, strengthen cross-team coordination, and elevate their overall approach to identifying and managing patients with aortic stenosis. Their feedback underscores a consistent theme: the program is driving meaningful momentum and setting the stage for stronger, more connected patient care.
Model Shares in Action
Site model shares highlight how Target: Aortic sites are integrating process improvements into their unique care environments. These shared examples provide practical insight into implementation strategies, team alignment, and process enhancements, giving peers a clearer view of what’s working in real-world settings. Together, they create a valuable exchange of knowledge that supports continuous improvement across the initiative.
Resources
Sponsor
Edwards Lifesciences is the national sponsor of Ãå±±ÊÓÆµ’s Target: Aortic Stenosis.